FindTrial
Sign In

Pravastatin Improves Endothelial Microparticles for the evaluation the Endothelial function of Patients with Variant Angina

Pravastatin Improves Endothelial Microparticles for the evaluation the Endothelial function of Patients with Variant Angina

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006541
Enrollment
45
Registered
2021-09-03
Start date
2017-03-08
Completion date
Unknown
Last updated
2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Yeouido St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Patients diagnosed with metamorphosis angina - Patients with hypercholesterolemia requiring statin treatment - who agree to informed consent

Exclusion criteria

Exclusion criteria: Patients with allergy and contraintication in Statin - Patients who need to use statins other than Pravastatin - Patients who need to use Fenofibrate or Iomega-3 together. - Pregnancy

Design outcomes

Primary

MeasureTime frame
Reduction of serum EMP before and after administration—

Secondary

MeasureTime frame
Frequency of chest pain and number of use of nitroglycerine sublingual—

Countries

Korea, Republic of

Contacts

Public ContactYun-Seok Choi

The Catholic University of Korea, Seoul St. Mary's Hospital

cys71@catholic.ac.kr+82-2-2258-1430

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026